Home › Funds › Opaleye Management Inc. › PHAT

Opaleye Management Inc. position in PHAT

Phathom Pharmaceuticals, Inc. · Health Care

Opaleye Management Inc. reported holding 185,589 shares of PHAT (Phathom Pharmaceuticals, Inc.) in its Q2 2026 13F filing — a position valued at US$2.0M, representing 0.18% of its reported portfolio and ranking #46 among its reported holdings. Opaleye Management Inc. first reported this position in Q2 2026.

Latest position (Q2 2026)185.59K sh
Reported value held$2.01M
Portfolio Weight0.18%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s PHAT position evolved

Opaleye Management Inc. first disclosed a stake in PHAT in Q2 2026 at 185,589 shares (US$2.0M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 185.59K $2.01M New

About PHAT and 13F data

PHAT (Phathom Pharmaceuticals, Inc.) is a Health Care company. 31 other funds we track also report a position in PHAT — the largest reported positions include Frazier Life Sciences Management, L.P. (US$135.3M), Medicxi Ventures Management (Jersey) Ltd (US$81.0M), Carlyle Group Inc. (US$37.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHAT

All PHAT fund holders →

FAQ

How long has Opaleye Management Inc. held PHAT?

Opaleye Management Inc. has disclosed PHAT holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Opaleye Management Inc.'s current position in PHAT?

As of Q2 2026, Opaleye Management Inc. holds 185.59K shares of PHAT (Phathom Pharmaceuticals, Inc.), valued at $2.01M, representing 0.18% of its reported portfolio and ranking #46.

Has Opaleye Management Inc. been buying or selling PHAT?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. newly opened its position in PHAT.

Which other funds hold PHAT?

Other major institutional holders of PHAT include Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Carlyle Group Inc., among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.